BioScience Health Innovations, Inc.
NOTR
$9.01
-$0.99-9.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.85M | 1.54M | 1.16M | 842.90K | 597.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.85M | 1.54M | 1.16M | 842.90K | 597.60K |
| Cost of Revenue | 536.00K | 331.90K | 215.50K | 151.20K | 113.10K |
| Gross Profit | 1.31M | 1.21M | 942.00K | 691.60K | 484.40K |
| SG&A Expenses | 1.22M | 1.17M | 1.02M | 925.70K | 735.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.76M | 1.50M | 1.23M | 1.08M | 849.10K |
| Operating Income | 87.00K | 38.60K | -74.70K | -234.20K | -251.50K |
| Income Before Tax | 87.00K | 38.60K | -74.70K | -234.20K | -251.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.09 | 0.04 | -0.07 | -0.23 | -0.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.00K | 38.60K | -74.70K | -234.20K | -251.50K |
| EBIT | 87.00K | 38.60K | -74.70K | -234.20K | -251.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 167.73M | 165.86M | 164.13M | 162.38M | 134.85M |
| Average Diluted Shares Outstanding | 169.41M | 165.86M | 164.13M | 162.38M | 134.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |